1-1 of 1
Sivahari P Gorantla, M.Sc.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Mechanisms of JAK2V617F Oncogenic Activation: The JAK2- V617F Mutant Utilizes the SH2 Domain for Constitutive Kinase Activity in the Presence of Unstimulated Heterodimeric Cytokine Receptor.

Sivahari P Gorantla, M.Sc., Tobias Dechow, M.D., Rebekka Grundler, Ph.D, Christian Peschel, MD, Justus Duyster
Journal: Blood
Blood (2008) 112 (11): 175.
https://doi.org/10.1182/blood.V112.11.175.175
Published: 2008